Target General Infomation
Target ID
T67658
Former ID
TTDR00776
Target Name
Solute carrier family 2, facilitated glucose transporter, member 4
Gene Name
SLC2A4
Synonyms
Glucose transporter type 4, insulin-responsive; Glut4 protein; SLC2A4
Target Type
Clinical Trial
Disease Type 2 diabetes [ICD9: 250; ICD10: E11]
Function
Insulin-regulated facilitative glucose transporter.
BioChemical Class
Major facilitator superfamily
UniProt ID
Sequence
MPSGFQQIGSEDGEPPQQRVTGTLVLAVFSAVLGSLQFGYNIGVINAPQKVIEQSYNETW
LGRQGPEGPSSIPPGTLTTLWALSVAIFSVGGMISSFLIGIISQWLGRKRAMLVNNVLAV
LGGSLMGLANAAASYEMLILGRFLIGAYSGLTSGLVPMYVGEIAPTHLRGALGTLNQLAI
VIGILIAQVLGLESLLGTASLWPLLLGLTVLPALLQLVLLPFCPESPRYLYIIQNLEGPA
RKSLKRLTGWADVSGVLAELKDEKRKLERERPLSLLQLLGSRTHRQPLIIAVVLQLSQQL
SGINAVFYYSTSIFETAGVGQPAYATIGAGVVNTVFTLVSVLLVERAGRRTLHLLGLAGM
CGCAILMTVALLLLERVPAMSYVSIVAIFGFVAFFEIGPGPIPWFIVAELFSQGPRPAAM
AVAGFSNWTSNFIIGMGFQYVAEAMGPYVFLLFAVLLLGFFIFTFLRVPETRGRTFDQIS
AAFHRTPSLLEQEVKPSTELEYLGPDEND
Drugs and Mode of Action
Drug(s) DS-1150b Drug Info Phase 1 Type 2 diabetes [524558]
Modulator DS-1150b Drug Info [551213]
Target Expression Profile (TEP) and Drug Resistance Mutation (DRM)
TEP EXP Info
Pathways
KEGG Pathway FoxO signaling pathway
AMPK signaling pathway
Insulin signaling pathway
Adipocytokine signaling pathway
Type II diabetes mellitus
Pathway Interaction Database Arf6 trafficking events
Insulin-mediated glucose transport
Class I PI3K signaling events mediated by Akt
PathWhiz Pathway Glucose-Alanine Cycle
Insulin Signalling
Reactome Translocation of GLUT4 to the plasma membrane
Transcriptional regulation of white adipocyte differentiation
Facilitative Na+-independent glucose transporters
Glucose transport
WikiPathways Glycolysis and Gluconeogenesis
Insulin Signaling
NRF2 pathway
Vitamin D Receptor Pathway
Translocation of GLUT4 to the Plasma Membrane
Transcriptional Regulation of White Adipocyte Differentiation
Adipogenesis
Cori Cycle
Hexose transport
Type II diabetes mellitus
AMPK Signaling
References
Ref 524558ClinicalTrials.gov (NCT02004678) Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of DS-1150b in Healthy Subjects and Subjects With Type-2 Diabetes Mellitus. U.S. National Institutesof Health.
Ref 551213Sanford-Burnham goes fourth. SciBX 7(22); doi:10.1038/scibx.2014.633. June 5 2014

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.